NewGenIvf Group Limited (NIVF)
NASDAQ: NIVF · Real-Time Price · USD
1.030
-0.100 (-8.85%)
At close: Jun 27, 2025, 4:00 PM
0.9900
-0.0400 (-3.88%)
After-hours: Jun 27, 2025, 7:58 PM EDT

Company Description

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan.

The company’s fertility treatment solutions include in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing.

It also provides IVF treatment; surrogacy and ancillary caring services, including regular body check, as well as vitamins, supplements, and medicines to surrogate mothers; and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment.

The company offers its services through its clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.

NewGenIvf Group Limited
NewGenIvf Group logo
Country Thailand
Founded 2011
Industry Medical Care Facilities
Sector Healthcare
Employees 76
CEO Wing Fung Siu

Contact Details

Address:
PS Tower, 13th Floor, Unit 36/39-36/40
Bangkok, 10110
Thailand
Phone 66 2 116 9641
Website newgenivf.com

Stock Details

Ticker Symbol NIVF
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001981662
CUSIP Number G0544E121
ISIN Number VGG0544E1051
SIC Code 8090

Key Executives

Name Position
Wing Fung Siu Co-Founder, Chairman and Chief Executive Officer
Hei Yue Fong Co-Founder, Chief Marketing Officer and Director
Fai Chung Ho Chief Financial Officer

Latest SEC Filings

Date Type Title
Jun 20, 2025 6-K Report of foreign issuer
Jun 17, 2025 6-K Report of foreign issuer
Jun 4, 2025 6-K Report of foreign issuer
Jun 3, 2025 EFFECT Notice of Effectiveness
Jun 3, 2025 424B3 Prospectus
Jun 2, 2025 6-K Report of foreign issuer
May 29, 2025 F-1/A [Amend] Registration statement for certain foreign private issuers
May 20, 2025 F-1/A [Amend] Registration statement for certain foreign private issuers
May 15, 2025 20-F/A Filing
May 1, 2025 F-1/A [Amend] Registration statement for certain foreign private issuers